Digestive system diseases

Management of patients with inflammatory bowel disease: current and future treatments

Inflammatory bowel disease (IBD) is characterised by chronic inflammation of the gastrointestinal tract and affects patients’ quality of life. Treatment of IBD involves induction and maintenance of remission. Current available therapies include anti-inflammatory aminosalicylates and corticoste…

The Unbeatables: a new team of superheroes of the inflammatory bowel disease community

Superheroes are known to be inspirational, shaping our culture and beliefs and expanding our understanding of the world. And now superheroes are helping us fight for our health. Takeda Pharmaceuticals is the first pharmaceutical company to partner with Marvel Custom Solutions on a global disea…

European conditional approval given for rare liver disease drug

The European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended a new drug to treat a rare and potentially lethal liver disease for conditional marketing approval across the EU.  Obeticholic acid (Ocaliva; Intercept Pharma) has been re…

Irritable bowel syndrome drug given green light for use in Europe

The European Commission has granted a marketing authorisation to a first-in-class treatment for irritable bowel syndrome (IBS) called eluxadoline (Truberzi) for use in the EU.…

Biosimilars and inflammatory bowel disease: a switch programme using CT-P13

How to plan and manage switching patients from a biologic to a biosimilar in inflammatory bowel disease, using the University Hospital Southampton NHS Foundation Trust’s experience as an example.…

Community pharmacy could detect unknown cases of coeliac disease

A proof of concept study has shown how opportunistic testing in community pharmacies may help identify those with coeliac disease who would not otherwise have been tested.…

How to tailor medication formulations for patients with dysphagia

An overview of dysphagia and how to ensure patients are receiving the safest and most efficacious oral formulations.…

Obeticholic acid gets US approval for rare liver disease

The US Food and Drug Administration has approved a new drug called Ocaliva (obeticholic acid) for patients with primary biliary cholangitis. …

Meet the regional finalists of I Love My Pharmacist: Southern England and the Channel Islands

The public has until 21 July 2016 to vote for their favourite regional finalist of the 2016 I Love My Pharmacist Award. The pharmacist with the highest number of votes in each region will then meet with the judging panel who will decide the 2016 champion.…

Viral suppression restores life expectancy in hepatitis C-related cirrhosis

Study shows sustained virologic response in patients with hepatitis C and cirrhosis dramatically improves survival.…